The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors

被引:5
作者
Wang, Jieyu [1 ,2 ]
Chen, Ruifang [1 ]
Li, Jun [1 ]
Lu, Xin [1 ,2 ]
机构
[1] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, 128 Shenyang Rd, Shanghai 200090, Peoples R China
[2] Fudan Univ, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
基金
中国国家自然科学基金; 上海市自然科学基金;
关键词
Malignant ovarian germ cell tumor; Lymphadenectomy; Log odds of positive lymph nodes; Prognosis; LYMPH-NODE METASTASIS; LOG-ODDS; PROGNOSTIC-FACTORS; CANCER PATIENTS; STAGE-I; MANAGEMENT; SURVEILLANCE; SURGERY; IMPACT; END;
D O I
10.1007/s00404-020-05772-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose To evaluate the therapeutic role of lymphadenectomy on patients with malignant ovarian germ cell tumor (MOGCT) and to investigate the risk factors of lymph node metastasis. Methods Patients of MOGCT between 1988 and 2013 with definite lymph node information were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Survival curves were estimated using the Kaplan-Meier method, and Cox regression analyses were performed to evaluate the effects of clinical and pathologic variables on survival. Results 2424 MOGCT patients with information on lymph nodes were included. Of the entire cohort, 46.2% patients received lymphadenectomy. The most common (42.2%) histologic type was teratoma, and 70.6% patients had FIGO stage I disease. Cox proportional model verified that age, grade, and log odds of positive lymph nodes (LODDS) were independent prognostic factors. Subgroup analysis showed that the association between the lymph node resection and better survival in the different age cohort. Conclusions Lymphadenectomy is not recommended for children (0-14 years). For patients 40 years of age and older, and for those who have the dysgerminoma type or endodermal sinus type, lymphadenectomy had an outstanding therapeutic role. As a parameter to assess lymph node status, LODDS could be used to classify MOGCTs.
引用
收藏
页码:1441 / 1450
页数:10
相关论文
共 37 条
  • [1] Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003
    Arora, Ramandeep S.
    Alston, Robert D.
    Eden, Tim O. B.
    Geraci, Marco
    Birch, Jillian M.
    [J]. CANCER, 2012, 118 (17) : 4290 - 4297
  • [2] Chatchotikawong Usanee, 2015, Asian Pac J Cancer Prev, V16, P1609
  • [3] Ratio and log odds of positive lymph nodes in breast cancer patients with mastectomy
    Chen, Li-Ju
    Chung, Kuo-Piao
    Chang, Yao-Jen
    Chang, Yun-Jau
    [J]. SURGICAL ONCOLOGY-OXFORD, 2015, 24 (03): : 239 - 247
  • [4] Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching
    Chen, Ying
    Ning, Yang
    Zhang, Qinghua
    Xie, Ying
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2018, 21 (09) : 652 - 661
  • [5] Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium
    Di Re, F
    Baiocchi, G
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (06) : 435 - 442
  • [6] Elashry Rasha, 2013, J Exp Ther Oncol, V10, P181
  • [7] Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older
    Feldman, Darren R.
    Voss, Martin H.
    Jacobsen, Erin P.
    Jia, Xiaoyu
    Suarez, J. Andres
    Turkula, Stefan
    Sheinfeld, Joel
    Bosl, George J.
    Motzer, Robert J.
    Patil, Sujata
    [J]. CANCER, 2013, 119 (14) : 2574 - 2581
  • [8] Revised Risk Classification for Pediatric Extracranial Germ Cell Tumors Based on 25 Years of Clinical Trial Data From the United Kingdom and United States
    Frazier, A. Lindsay
    Hale, Juliet P.
    Rodriguez-Galindo, Carlos
    Dang, Ha
    Olson, Thomas
    Murray, Matthew J.
    Amatruda, James F.
    Thornton, Claire
    Arul, G. Suren
    Billmire, Deborah
    Shaikh, Furqan
    Pashankar, Farzana
    Stoneham, Sara
    Krailo, Mark
    Nicholson, James C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (02) : 195 - U104
  • [9] Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary
    Gershenson, David M.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 515 - 517
  • [10] The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies
    Harlan, LC
    Hankey, BF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2232 - 2233